PT  - JOURNAL ARTICLE
AU  - Manuela Runge
AU  - Reese A.K. Richardson
AU  - Patrick Clay
AU  - Arielle Eagan
AU  - Tobias M. Holden
AU  - Manisha Singam
AU  - Natsumi Tsuboyama
AU  - Philip Arevalo
AU  - Jane Fornoff
AU  - Sarah Patrick
AU  - Ngozi O. Ezike
AU  - Jaline Gerardin
TI  - Modeling robust COVID-19 intensive care unit occupancy thresholds for imposing mitigation to prevent exceeding capacities
AID  - 10.1101/2021.06.27.21259530
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.06.27.21259530
4099  - http://medrxiv.org/content/early/2021/07/03/2021.06.27.21259530.short
4100  - http://medrxiv.org/content/early/2021/07/03/2021.06.27.21259530.full
AB  - In managing COVID-19 with non-pharmaceutical interventions, occupancy of intensive care units (ICU) is often used as an indicator to inform when to intensify mitigation and thus reduce SARS-CoV-2 transmission, strain on ICUs, and deaths. However, ICU occupancy thresholds at which action should be taken are often selected arbitrarily. We propose a quantitative approach using mathematical modeling to identify ICU occupancy thresholds at which mitigation should be triggered to avoid exceeding the ICU capacity available for COVID-19 patients. We used a stochastic compartmental model to simulate SARS-CoV-2 transmission and disease progression, including critical cases that would require intensive care. We calibrated the model for the United States city of Chicago using daily COVID-19 ICU and hospital census data between March and August 2020. We projected ICU occupancies from September to May 2021 under two possible levels of transmission increase. The effect of combined mitigation measures was modeled as a decrease in the transmission rate that took effect when projected ICU occupancy reached a specified threshold. We found that mitigation did not immediately eliminate the risk of exceeding ICU capacity. Delaying action by 7 days increased the probability of exceeding ICU capacity by 10-60% and this increase could not be counteracted by stronger mitigation. Even under modest transmission increase, a threshold occupancy no higher than 60% was required when mitigation reduced the reproductive number Rt to just below 1. At higher transmission increase, a threshold of at most 40% was required with mitigation that reduced Rt below 0.75 within the first two weeks after mitigation. Our analysis demonstrates a quantitative approach for the selection of ICU occupancy thresholds that considers parameter uncertainty and compares relevant mitigation and transmission scenarios. An appropriate threshold will depend on the location, number of ICU beds available for COVID-19, available mitigation options, feasible mitigation strengths, and tolerated durations of intensified mitigation.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNorthwestern University IRB ruled that this study is not HSRFunding StatementMR, AE, and JG were supported by a MIDAS rapid response grant (MIDASNI2020-4). MR was supported by a COVID-19 rapid response grant via NUCATS (UL1TR001422). MR and JG were supported by a BMGF grant (INV-002092). RR was supported by a grant from NIGMS (T32 GM008449). TMH was supported by a grant from NIGMS (T32 GM008152). The funders had no role in the design of the study and collection, analysis, and interpretation of data or in writing the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Northwestern University IRB ruled that this study is not HSR.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe simulation and analysis code are publicly available on GitHub under https://github.com/numalariamodeling/ICUtrigger_covid_chicago_paper_2021. The simulation outputs are stored on Zenodo with DOI:10.5281/zenodo.5018779. The COVID-19 transmission model is maintained under https://github.com/numalariamodeling/covid-chicago. Public data is available on the IDPH website (https://dph.illinois.gov/covid19). Illinois hospital census data and I-NEDSS data can be received from IDPH upon reasonable request. All other data are publicly available as mentioned in the text. https://doi.org/10.5281/zenodo.5018779 CMSCompartmental Modeling SoftwareICUIntensive care unitIDPHIllinois Department for Public HealthI-NEDSSIllinois National Electronic Disease Surveillance SystemMed/surgMedical/surgery hospital inpatient bedsPIPrediction intervalSARS-CoV-2Severe acute respiratory syndrome coronavirus 2RtTime varying reproductive number (also effective reproductive number Reff)